David Abrams - Abrams Capital Management 13F Activity & Position Changes (Q3 2022)

According to the SEC 13F filed on Nov 10, 2022, the Abrams Capital Management portfolio showed several notable changes in holdings as of quarter-end Sep 30, 2022. The activity included new positions, additions to existing holdings, reductions, and complete exits, providing a clear view of how the portfolio evolved during the quarter.

During Q3 2022, the filing reported:

New Buys - None reported

Increases - Alphabet Inc.

Reductions - Coupang, Inc., Energy Transfer LP, Kinder Morgan, Inc., Teva Pharmaceutical Industries , USCB Financial Holdings, Inc.

Complete Exits - None reported

These updates highlight how the portfolio adjusted across different sectors and market conditions, offering insights into allocation shifts and investment trends.

Date	Symbol	Name	Type	Change Qty	% Change	Value	Remaining
Q3 2022	CPNG Coupang, Inc.	Coupang, Inc.	Sell	-208,045	-1.5%	$223.29K	13,395,026
Q3 2022	ET Energy Transfer LP	Energy Transfer LP	Sell	-105,000	-0.5%	$242.87K	22,019,322
Q3 2022	GOOGL Alphabet Inc.	Alphabet Inc.	Buy	+2,764,160	+1887.6%	$278.40K	2,910,600
Q3 2022	KMI Kinder Morgan, Inc.	Kinder Morgan, Inc.	Sell	-9,098,512	-72.9%	$56.20K	3,377,688
Q3 2022	TEVA Teva Pharmaceutical Industries	Teva Pharmaceutical Industries	Sell	-147,060	-0.6%	$192.87K	23,899,296
Q3 2022	USCB USCB Financial Holdings, Inc.	USCB Financial Holdings, Inc.	Sell	-13,960	-1.6%	$11.08K	845,394